| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/05/2007 | US20070154543 Solid preparation for oral use |
| 07/05/2007 | US20070154542 Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors |
| 07/05/2007 | US20070154541 Seamless capsule containing water-soluble active substance |
| 07/05/2007 | US20070154540 Composition for treatment of osteoarthritis containing apigenin as chondroregenerative agent |
| 07/05/2007 | US20070154538 Removal of fat cells by PDT |
| 07/05/2007 | US20070154537 Lipid-derivatized bisphosphonic acid |
| 07/05/2007 | US20070154535 Tulobuterol adhesive patch |
| 07/05/2007 | US20070154533 Method of increasing testosterone and related steriod concentrations in women |
| 07/05/2007 | US20070154532 Compositions comprising vitamins and/or derivatives thereof stablished with olea europea extract and/or ionene polymers |
| 07/05/2007 | US20070154531 Anti-inflammatory analgesic preparation |
| 07/05/2007 | US20070154527 Topical film compositions for delivery of actives |
| 07/05/2007 | US20070154523 Controlled pupil dilation for diagnostic and treatment of visual anomalies |
| 07/05/2007 | US20070154521 Tri-branched biologically active copolymer |
| 07/05/2007 | US20070154516 Drug delivery system |
| 07/05/2007 | US20070154498 Intravenous essential fatty acid emulsion |
| 07/05/2007 | US20070154497 Stable, palatable syrup containing ibuprofen and method of its preparation |
| 07/05/2007 | US20070154486 Nucleic acid molecule comprising a nucleic acid sequence coding for a haemocyanin |
| 07/05/2007 | US20070154483 Treatment with anti-vegf antibodies |
| 07/05/2007 | US20070154482 Methods and compositions for the treatment and diagnosis of diseases characterized by vascular leak, hypotension, or a procoagulant state |
| 07/05/2007 | US20070154466 Internal medical devices containing peroxide-converting catalysts |
| 07/05/2007 | US20070154457 Use of eIF-5A to kill multiple myeloma cells |
| 07/05/2007 | US20070154452 Therapeutic agent for pancreas cancer |
| 07/05/2007 | US20070154447 Linear polyethylenimine-sterol conjugates for gene delivery |
| 07/05/2007 | US20070154436 Non-Absorbent Articles Including Aromatic Compositions As Inhibitors Of Exoprotein Production |
| 07/05/2007 | US20070154435 Compositions and methods for skin conditioning |
| 07/05/2007 | US20070154432 Compositions and methods for hair growth |
| 07/05/2007 | US20070154428 Thiazole derivative |
| 07/05/2007 | US20070154408 Inhalable biodegradable microparticles for target-specific drug delivery in tuberculosis and a process thereof |
| 07/05/2007 | US20070154402 Topical Pharmaceutical Foam Composition |
| 07/05/2007 | US20070154401 Compositions and methods for enhanced mucosal delivery of parathyroid hormone |
| 07/05/2007 | US20070154400 Compositions and methods for enhanced mucosal delivery of parathyroid hormone |
| 07/05/2007 | US20070154398 Block copolymers and nano micelles comprising the same |
| 07/05/2007 | US20070154369 Thickening zone, reaction zone, cooling zone, and an exit zone in an effluent manifold in a centrifuge; both supercritical and subcritical oxidaton; is inexpensive, relatively simple to operate, allows continuous processing of relatively high flow rates, and is easy to maintain and repair. |
| 07/05/2007 | DE20122736U1 Beschichteter Ballonkatheter Coated balloon catheter |
| 07/05/2007 | DE10334188B4 Verwendung von Rotigotin zur Behandlung von Depressionen Use of rotigotine for treatment of depression |
| 07/05/2007 | DE102005062991A1 Substituierte Thiazole und ihre Verwendung zur Herstellung von Arzneimitteln Substituted thiazoles and their use for the preparation of medicaments |
| 07/05/2007 | DE102005062990A1 Substituierte Thiazole und ihre Verwendung zur Herstellung von Arzneimitteln Substituted thiazoles and their use for the preparation of medicaments |
| 07/05/2007 | DE102005062987A1 Substituierte Propiolsäureamide und ihre Verwendung zur Herstellung von Arzneimitteln Substituted Propiolsäureamide and their use for the preparation of medicaments |
| 07/05/2007 | DE102005062986A1 Substituierte Propiolsäureamide und ihre Verwendung zur Herstellung von Arzneimitteln Substituted Propiolsäureamide and their use for the preparation of medicaments |
| 07/05/2007 | DE102005062985A1 Substituierte bis(hetero)aromatische N-Ethylpropiolamide und ihre Verwendung zur Herstellung von Arzneimitteln Substituted bis (hetero) aromatic N-Ethylpropiolamide and their use for the preparation of medicaments |
| 07/05/2007 | DE102005061520A1 Verwendung von Wirkstoffen, die die Adhäsion von Mikroorganismen an Hautzellen verhindern, zur kosmetischen Verbesserung von Hautalterungserscheinungen, besonders Altersflecken Use of agents that prevent the adhesion of microorganisms to skin cells for the cosmetic improvement of skin aging, particularly age spots |
| 07/05/2007 | DE102005061430A1 Substituierte Imidazolin-Derivate Substituted imidazoline derivatives |
| 07/05/2007 | DE102005061426A1 Substituierte tricyclische Piperidon-Derivate Substituted tricyclic piperidone derivatives |
| 07/05/2007 | DE102005061171A1 Neue, cyclisch substituierte Furopyrimidin-Derivate und ihre Verwendung New, cyclic, substituted Furopyrimidin derivatives and their use |
| 07/05/2007 | DE102005061170A1 Neue, acyclisch substituierte Furopyrimidin-Derivate und ihre Verwendung New acyclic Furopyrimidin substituted derivatives and their use |
| 07/05/2007 | DE102005054700A1 Neue duale Peptidase-Inhibitoren als Prodrugs zur Therapie von entzündlichen und anderen Erkrankungen New dual peptidase inhibitors as prodrugs for the treatment of inflammatory and other diseases |
| 07/05/2007 | CA2845158A1 Compositions and methods for preventing or treating inflammatory bowel disease |
| 07/05/2007 | CA2826746A1 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide |
| 07/05/2007 | CA2821393A1 Rnai-mediated inhibition of rho kinase for treatment of ocular hypertension/glaucoma |
| 07/05/2007 | CA2753405A1 Nitrogen-containing bicyclic heteroaryl compounds and methods of use |
| 07/05/2007 | CA2752337A1 Improved oral compositions comprising zinc citrate and/or tocopherol agents |
| 07/05/2007 | CA2646974A1 Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid |
| 07/05/2007 | CA2642130A1 Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors |
| 07/05/2007 | CA2635777A1 Combination therapy for diabetes |
| 07/05/2007 | CA2635770A1 Inhibition of cxcr4 and/or cell motility by phenylalanine, cysteine or peptides containing said aminoacids |
| 07/05/2007 | CA2635422A1 Testosterone stabilisation in transdermal devices |
| 07/05/2007 | CA2635392A1 New pyrrolic derivatives with histone deacetylase inhibitory activity |
| 07/05/2007 | CA2635388A1 Use of alpha-hydroxy carbonyl compounds as reducing agents |
| 07/05/2007 | CA2635381A1 Hemostatic material |
| 07/05/2007 | CA2635379A1 Hemostatic material |
| 07/05/2007 | CA2635375A1 Synergistic effect between a cyanogenic system and another oxidative inducer for the treatment of tumours |
| 07/05/2007 | CA2635359A1 Compositions and methods for synthesizing heterocyclic therapeutic compounds |
| 07/05/2007 | CA2635038A1 Method for modifying gut flora in animals |
| 07/05/2007 | CA2634999A1 Muscarinic agonists and methods of use thereof |
| 07/05/2007 | CA2634969A1 Controlled release solid preparation |
| 07/05/2007 | CA2634940A1 Treatment of nonalcoholic fatty liver disease using cholesterol lowering agents and h3 receptor antagonist/inverse agonist |
| 07/05/2007 | CA2634923A1 Acetylenic bicyclic heteroaryl compounds useful as kinase inhibitors |
| 07/05/2007 | CA2634907A1 Oxazoloisoquinoline derivatives as thrombin receptor antagonists |
| 07/05/2007 | CA2634847A1 Substituted aniline derivatives useful as histamine h3 antagonists |
| 07/05/2007 | CA2634846A1 Novel arylamidine derivative, salt thereof and antifungal agent containing those |
| 07/05/2007 | CA2634833A1 Pyridinyl amine derivatives as inhibitors of cholesteryl ester transfer protein (cetp) |
| 07/05/2007 | CA2634794A1 Macrocyclic factor viia inhibitors useful as anticoagulants |
| 07/05/2007 | CA2634787A1 Azaindole inhibitors of aurora kinases |
| 07/05/2007 | CA2634768A1 3-aryl-substituted quinazolones, and uses thereof |
| 07/05/2007 | CA2634749A1 Process for preparing a synthetic intermediate for preparation of branched nucleosides |
| 07/05/2007 | CA2634746A1 Processes for taxane derivatives and intermediates useful therein |
| 07/05/2007 | CA2634723A1 Orally active purine-based inhibitors of heat shock protein 90 |
| 07/05/2007 | CA2634721A1 Triazolopyridazines as tyrosine kinase modulators |
| 07/05/2007 | CA2634639A1 Complex formulation comprising amlodipine camsylate and simvastatin and method for preparation thereof |
| 07/05/2007 | CA2634637A1 Controlled release solid preparation |
| 07/05/2007 | CA2634630A1 Process for the preparation of porphyrin derivatives as antimicrobial agents by photodynamic therapy (pdt) |
| 07/05/2007 | CA2634598A1 Treatment of synucleinopathies |
| 07/05/2007 | CA2634542A1 Incontinence treatment methods |
| 07/05/2007 | CA2634456A1 Modulators of muscarinic receptors |
| 07/05/2007 | CA2634442A1 Calcium channel antagonists |
| 07/05/2007 | CA2634437A1 4,7-dihydrothieno¬2,3-b|pyridine compounds and pharmaceutical compositions |
| 07/05/2007 | CA2634413A1 Method and system for the delivery of corticosteroids having an enhanced pharmacokinetic profile |
| 07/05/2007 | CA2634398A1 Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile |
| 07/05/2007 | CA2634394A1 Homogeneous paste formulations |
| 07/05/2007 | CA2634255A1 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder |
| 07/05/2007 | CA2634250A1 Phenoxypiperidines and analogs thereof useful as histamine h3 antagonists |
| 07/05/2007 | CA2634232A1 Method of producing solid preparation disintegrating in the oral cavity |
| 07/05/2007 | CA2634216A1 Thrombin receptor antagonists as prophylaxis to complications from cardiopulmonary surgery |
| 07/05/2007 | CA2634198A1 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 07/05/2007 | CA2634139A1 Omega 3 fatty acid formulations |
| 07/05/2007 | CA2634115A1 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain |
| 07/05/2007 | CA2634113A1 Quinolin- 4 - one derivatives as modulators of abc transporters |
| 07/05/2007 | CA2634112A1 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression |
| 07/05/2007 | CA2634111A1 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of epilepsy |
| 07/05/2007 | CA2634110A1 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction |